| Dr Paige S Charleston, MD | |
|
717 N 190th Plz, Ste. 1100, Elkhorn, NE 68022-3917 | |
| (402) 815-1700 | |
| (402) 815-1959 |
| Full Name | Dr Paige S Charleston |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 29 Years |
| Location | 717 N 190th Plz, Elkhorn, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366555369 | NPI | - | NPPES |
| 47069731799 | Medicaid | NE | |
| 1366555369 | Medicaid | IA | |
| 10026301600 | Medicaid | NE |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Nebraska Methodist Hospital | Omaha, NE | Hospital |
| Methodist Fremont Health | Fremont, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians Clinic Inc | 4880506062 | 497 |
News Archive
The chances for President Barack Obama and the Democratic Congress to enact health reform is being weighed by a number of analysts, who are handicapping the outcome based on past and present experiences.
"President Barack Obama may rely only on Democrats to push health-care legislation through the U.S. Congress if Republican resistance doesn't eventually give way, two of the president's top advisers said," Bloomberg reports.
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
Patients with sickle cell disease rely more on the emergency room as they move from pediatric to adult health care, according to researchers at Washington University School of Medicine in St. Louis.
Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2010.
› Verified 5 days ago
| Entity Name | Physicians Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821049156 PECOS PAC ID: 4880506062 Enrollment ID: O20031105000345 |
News Archive
The chances for President Barack Obama and the Democratic Congress to enact health reform is being weighed by a number of analysts, who are handicapping the outcome based on past and present experiences.
"President Barack Obama may rely only on Democrats to push health-care legislation through the U.S. Congress if Republican resistance doesn't eventually give way, two of the president's top advisers said," Bloomberg reports.
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
Patients with sickle cell disease rely more on the emergency room as they move from pediatric to adult health care, according to researchers at Washington University School of Medicine in St. Louis.
Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2010.
› Verified 5 days ago
| Entity Name | Nebraska Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689628372 PECOS PAC ID: 6901707447 Enrollment ID: O20040116000781 |
News Archive
The chances for President Barack Obama and the Democratic Congress to enact health reform is being weighed by a number of analysts, who are handicapping the outcome based on past and present experiences.
"President Barack Obama may rely only on Democrats to push health-care legislation through the U.S. Congress if Republican resistance doesn't eventually give way, two of the president's top advisers said," Bloomberg reports.
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
Patients with sickle cell disease rely more on the emergency room as they move from pediatric to adult health care, according to researchers at Washington University School of Medicine in St. Louis.
Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2010.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paige S Charleston, MD Po Box 3755, Omaha, NE 68103-0755 Ph: (402) 354-2100 | Dr Paige S Charleston, MD 717 N 190th Plz, Ste. 1100, Elkhorn, NE 68022-3917 Ph: (402) 815-1700 |
News Archive
The chances for President Barack Obama and the Democratic Congress to enact health reform is being weighed by a number of analysts, who are handicapping the outcome based on past and present experiences.
"President Barack Obama may rely only on Democrats to push health-care legislation through the U.S. Congress if Republican resistance doesn't eventually give way, two of the president's top advisers said," Bloomberg reports.
Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).
Patients with sickle cell disease rely more on the emergency room as they move from pediatric to adult health care, according to researchers at Washington University School of Medicine in St. Louis.
Rigel Pharmaceuticals, Inc. today reported financial results for the first quarter ended March 31, 2010.
› Verified 5 days ago
Judith Ann Scott, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz, Ste. #1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Annamaria Nagy, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz, Ste 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Dr. Kristen L Hoffman, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 717 N 190th Plz, Ste. 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Neil A Hamill, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 No. 190th Plaza, Suite 2400, Elkhorn, NE 68022 Phone: 402-815-1970 Fax: 402-815-1595 | |
Mark D. Carlson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz, Ste. # 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Dr. Julia K Bishop, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz, Ste. 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 | |
Allison H. Phillips, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 717 N 190th Plz, Ste. 1100, Elkhorn, NE 68022 Phone: 402-815-1700 Fax: 402-815-1959 |